Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test (OTCQX:RHHBY)

Published on 11 Apr 2024 on Seeking Alpha

Roche and Eli Lilly's Elecsys pTau217 assay received FDA Breakthrough Device Designation for early...

Read the rest of the article

Start tracking your investments with Statfolio

Amidst a backdrop of fluctuating market conditions, the Swiss market demonstrated resilience, clo...

Simply Wall St. via Yahoo Finance 31 May 2024

Swiss stocks experienced a downturn on Tuesday, influenced by global economic concerns including ...

Simply Wall St. via Yahoo Finance 30 May 2024

On Thursday, Goldman Sachs initiated coverage on Roche Holding AG (OTC:RHHVF) (ROG:SW) (OTC: RHHB...

Investing.com 30 May 2024

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024

Roche Holding AG RHHBY announced that the FDA has accepted its new drug application (NDA) seeking...

Zacks via Yahoo Finance 29 May 2024

Novo Nordisk (NYSE: NVO) has been a fantastic, market-beating stock to own for the past decade. I...

Motley Fool via Yahoo Finance 25 May 2024

Roche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi ...

Zacks via Yahoo Finance 15 Apr 2024

Roche and Eli Lilly's Elecsys pTau217 assay received FDA Breakthrough Device Designation for earl...

Seeking Alpha 11 Apr 2024

Roche obtained CE Mark for its HER2 test, making it the first companion diagnostic for HER2-low...

Seeking Alpha 10 Apr 2024

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you wan...

Insider Monkey via Yahoo Finance 7 Apr 2024